Research workbench
PVHL54-213-elob-eloc complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisoxazol-5-YL)ACETYL)PYRROLIDINE-2- carboxamide
Analyse PVHL54-213-elob-eloc complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3ZTC
- Type
- protein
- Length
- 1,328 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
- UniProt
- Q15370, Q15369, P40337
- Ligands
- TR0
- Pockets
- 11 · best druggability 0.63
Structure
x-ray diffraction · 11 distinct chains · 27% helix, 28% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Transcription elongation factor B polypeptide 2 | protein | 103 | 18% helix, 35% strand | Q15370 |
| B | Transcription elongation factor B polypeptide 1 | protein | 86 | 48% helix, 15% strand | Q15369 |
| C | Von hippel-lindau disease tumor suppressor | protein | 141 | 23% helix, 30% strand | P40337 |
| D | Transcription elongation factor B polypeptide 2 | protein | 99 | 15% helix, 35% strand | Q15370 |
| E, K | Transcription elongation factor B polypeptide 1 | protein | 87 | 48% helix, 15% strand | Q15369 |
| F | Von hippel-lindau disease tumor suppressor | protein | 142 | 23% helix, 28% strand | P40337 |
| G | Transcription elongation factor B polypeptide 2 | protein | 105 | 24% helix, 36% strand | Q15370 |
| H | Transcription elongation factor B polypeptide 1 | protein | 86 | 48% helix, 15% strand | Q15369 |
| I | Von hippel-lindau disease tumor suppressor | protein | 145 | 26% helix, 29% strand | P40337 |
| J | Transcription elongation factor B polypeptide 2 | protein | 104 | 18% helix, 31% strand | Q15370 |
| L | Von hippel-lindau disease tumor suppressor | protein | 143 | 24% helix, 29% strand | P40337 |
Ligands and binding sites
- TR0 · (4R)-N-(biphenyl-4-ylmethyl)-4-hydroxy-1-[(3-methylisoxazol-5-yl)acetyl]-L-prolinamide · ligand · 4 copies · chains C, F, I, L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 348 | 0.63 | 0.79 | 44 | TR0 |
| 2 | 296 | 0.62 | 0.79 | 35 | TR0 |
| 3 | 120 | 0.55 | 0.82 | 23 | empty |
| 4 | 184 | 0.46 | 0.75 | 36 | empty |
| 5 | 76 | 0.45 | 0.81 | 17 | empty |
Interfaces
17 interfaces between chains.
- G–H · 1118 Ų buried · 16 hydrogen bonds · protein-protein
- J–K · 1114 Ų buried · 10 hydrogen bonds · protein-protein
- D–E · 1079 Ų buried · 11 hydrogen bonds · protein-protein
- A–B · 1066 Ų buried · 13 hydrogen bonds · protein-protein
- E–F · 1059 Ų buried · 13 hydrogen bonds · protein-protein
Compared structures
- 3ZTC · pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)… · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 3ZTC · PDBe 3ZTC · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.